v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
SALES $ 60,826 $ 87,083
COST OF SALES (excluding depreciation expense) 15,495 21,069
GROSS PROFIT 45,331 66,014
OPERATING EXPENSES:    
Compensation and related benefits (including stock-based compensation of $361,380 and $1,467,276 for the three months ended March 31, 2020 and 2019, respectively) 689,370 2,009,205
Research and development 2,390 8,102
Professional fees 136,541 231,442
General and administrative expenses 105,195 125,154
Total Operating Expenses 933,496 2,373,903
LOSS FROM OPERATIONS (888,165) (2,307,889)
OTHER EXPENSES:    
Derivative expense (378,920)
Interest expense (241,203) (52,534)
Total Other Expenses (620,123) (52,534)
NET LOSS $ (1,508,288) $ (2,360,423)
NET LOSS PER COMMON SHARE:    
Basic and diluted $ (0.01) $ (0.03)
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING:    
Basic and diluted 117,854,602 80,599,185

Source